ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Effect of Pretransplant Renal Replacement Therapy on Liver Transplant Outcomes

E. Asham, M. Boktour, C. Frenette, H. Monsour, W. Suki, A. Gaber, R. Ghobrial

Surgery, The Methodist Hospital, Houston, TX
Scripps Clinic for Organ Transplantation, Scripps Clinic &
Green Hospital, La Jolla, CA
Medicine, The Methodist Hospital, Houston, TX

Meeting: 2013 American Transplant Congress

Abstract number: D1692

Aim: To evaluate outcomes of cirrhotic patients who received renal replacement therapy prior to liver transplant.

Methods: A retrospective review of cirrhotic patients who received orthotopic liver transplantation (OLT) between April 2008 and July 2012. Out of 194 patients, 53 patients received renal replacement therapy (RRT).

Results: The 53 patients were divided into those who received liver only (n=35) and others who received combined liver kidney transplant; CLKT (n=18). The mean MELD score in the OLT was 39 + 5 SD while in the CLKT 29+ 6 SD. The median waiting times for OLT and CLKT were 15 and 99 days respectively. Post-transplant; 30 patients in the OLT group and 4 in the CLKT group received RRT till full recovery of kidney functions. After 21 months median follow up, survival data are:

Survival CLKT (n=18) OLT + pre Tx RRT (n=35) OLT without pre transplant RRT (n=141) P value
1-year patient survival 78% 86% 96% 0.006
1-Year graft survival 78% 82% 94% 0.01
3-year patient survival 72% 83% 89% 0.07
3-year graft survival 72% 78% 88% 0.003

Conclusion:

Post-transplant RRT requirement was higher in the OLT+ pre TxRRT group than CLKT. Patients who received liver only, had a significantly higher MELD scores, shorter waiting time and better survival. This reflects the component of kidney dysfunction that is reversible by restoring liver function. Patient who do not require pre transplant RRT have better 1- year overall survival 3- year graft survival.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Asham E, Boktour M, Frenette C, Monsour H, Suki W, Gaber A, Ghobrial R. Effect of Pretransplant Renal Replacement Therapy on Liver Transplant Outcomes [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/effect-of-pretransplant-renal-replacement-therapy-on-liver-transplant-outcomes/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences